Jefferies Starts Pacira Pharmaceuticals (PCRX) at Buy
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $25.90 -3.39%
Rating Summary:
16 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Rating Summary:
16 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Join SI Premium – FREE
Jefferies initiates coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with a Buy rating and a price target of $81.00.
For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $70.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pacira BioSciences (PCRX) August 20 and 25 put spreader active
- Goldman Sachs Starts Victoria's Secret (VSCO) at Sell
- Maxim Group Starts Lakeland Industries (LAKE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
